1. Cardiac dysfunction in cancer patients
- Author
-
Wolfgang A. Linke, Yuri D'Alessandra, Anikó Görbe, Péter Ferdinandy, Carlo G. Tocchetti, Michele Ciccarelli, Daniela Sorriento, Serena Zacchigna, Stephane Heymans, Dana Dawson, Manuel Mayr, Nazha Hamdani, Rosalinda Madonna, Pietro Ameri, Inês Falcão-Pires, Emilio Hirsch, Rudolf A. de Boer, Alexander R. Lyon, Michele Russo, Alessandra Ghigo, Bernadett Kiss, Mauro Giacca, Jolanda van der Velden, Thomas Thum, Luc Bertrand, Tocchetti, Carlo G, Ameri, Pietro, de Boer, Rudolf A, D'Alessandra, Yuri, Russo, Michele, Sorriento, Daniela, Ciccarelli, Michele, Kiss, Bernadett, Bertrand, Luc, Dawson, Dana, Falcao-Pires, Ine, Giacca, Mauro, Hamdani, Nazha, Linke, Wolfgang A, Mayr, Manuel, van der Velden, Jolanda, Zacchigna, Serena, Ghigo, Alessandra, Hirsch, Emilio, Lyon, Alexander R, Görbe, Anikó, Ferdinandy, Péter, Madonna, Rosalinda, Heymans, Stephane, Thum, Thomas, UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), RS: Carim - H02 Cardiomyopathy, and Cardiovascular Centre (CVC)
- Subjects
0301 basic medicine ,RNA, Untranslated ,HISTONE DEACETYLASE ,Physiology ,heart failure ,Disease ,Cell Communication ,030204 cardiovascular system & hematology ,Gut flora ,Multicellular ,cause of death ,0302 clinical medicine ,cardiovascular disease ,Risk Factors ,inflammatory cell ,Neoplasms ,Myocytes, Cardiac ,IMMUNE CHECKPOINT INHIBITORS ,cancer fibroblasts ,antineoplastic agent ,Cause of death ,stromal cells ,toxic effect ,whole genome sequencing ,biology ,CLONAL HEMATOPOIESIS ,aging ,cardiac myocytes ,myocardium ,inflammatory cells ,cardiovascular diseases ,endothelial cells ,antineoplastic agents ,medical oncology ,heart ,cellular biology ,cardiac function ,impaired microbiome ,european society of cardiology ,EUROPEAN-SOCIETY ,3. Good health ,Cell biology ,CHAIN FATTY-ACIDS ,PRESERVED EJECTION FRACTION ,CARDIOVASCULAR-DISEASE ,endothelial cell ,Cardio-Oncology ,Inflammation Mediators ,Cardiology and Cardiovascular Medicine ,Common pathways in heart failure and cancer ,Signal Transduction ,Cardiac function curve ,Stromal cell ,Heart Diseases ,cardiac myocyte ,Antineoplastic Agents ,Risk Assessment ,03 medical and health sciences ,LUNG-CANCER ,Multicellular and multiorgan mechanisms ,Physiology (medical) ,cancer fibroblast ,medicine ,Animals ,Humans ,Lung cancer ,business.industry ,Cancer ,stromal cell ,medicine.disease ,biology.organism_classification ,Cardiotoxicity ,Gastrointestinal Microbiome ,030104 developmental biology ,Gene Expression Regulation ,Multiorgan mechanisms ,Heart failure ,INFLAMMATORY RESPONSES ,business ,DOXORUBICIN-INDUCED CARDIOTOXICITY - Abstract
In western countries, cardiovascular (CV) disease and cancer are the leading causes of death in the ageing population. Recent epidemiological data suggest that cancer is more frequent in patients with prevalent or incident CV disease, in particular, heart failure (HF). Indeed, there is a tight link in terms of shared risk factors and mechanisms between HF and cancer. HF induced by anticancer therapies has been extensively studied, primarily focusing on the toxic effects that anti-tumour treatments exert on cardiomyocytes. In this Cardio-Oncology update, members of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart discuss novel evidence interconnecting cardiac dysfunction and cancer via pathways in which cardiomyocytes may be involved but are not central. In particular, the multiple roles of cardiac stromal cells (endothelial cells and fibroblasts) and inflammatory cells are highlighted. Also, the gut microbiota is depicted as a new player at the crossroads between HF and cancer. Finally, the role of non-coding RNAs in Cardio-Oncology is also addressed. All these insights are expected to fuel additional research efforts in the field of Cardio-Oncology.
- Published
- 2020